Evidence map›Paper›PMID 30087776›Full record

ArticleEndocrinology, diabetes & metabolism case reports2018

A patient with a germline

Michelle Maher, Federico Roncaroli, Nigel Mendoza, Karim Meeran, Natalie Canham, Monika Kosicka-Slawinska, Birgitta Bernhard, David Collier, Juliana Drummond, Kassiani Skordilis and 5 more

Open access · goldAbstract read
In one paragraph

Article in Endocrinology, diabetes & metabolism case reports, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.7field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 13 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 8 institutions in 2 countries.

Michelle MaherEndocrinology, Imperial College Healthcare NHS Trust, London, UK.
Federico RoncaroliUniversity of Manchester, Manchester, UK.
Nigel MendozaEndocrinology, Imperial College Healthcare NHS Trust, London, UK.
Karim MeeranEndocrinology, Imperial College Healthcare NHS Trust, London, UK.
Natalie CanhamLiverpool Womens NHS Foundation Trust, Liverpool, UK.
Monika Kosicka-SlawinskaLondon North West Healthcare NHS Trust, London, UK.
Birgitta BernhardLondon North West Healthcare NHS Trust, London, UK.
David CollierThe William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK.
Juliana DrummondThe William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK.
Kassiani SkordilisUniversity Hospitals Birmingham NHS Foundation Trust, Mindelsohn Way, Edgbaston, Birmingham, UK.
Nicola TuftonThe Royal London Hospital, Barts Health NHS Trust, London UK.
Anastasia GontsarovaEndocrinology, Imperial College Healthcare NHS Trust, London, UK.
Niamh MartinEndocrinology, Imperial College Healthcare NHS Trust, London, UK.
Márta KorbonitsThe William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK.
Florian WernigEndocrinology, Imperial College Healthcare NHS Trust, London, UK.
Imperial College Healthcare NHS Trust · GBWilliam Harvey Research Institute · GBLondon North West Healthcare NHS Trust · GBBarts Health NHS Trust · GBLiverpool Womens NHS Foundation Trust · GBOllscoil na Gaillimhe – University of Galway · IEUniversity Hospitals Birmingham NHS Foundation Trust · GBUniversity of Manchester · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Symptomatic pituitary adenomas occur with a prevalence of approximately 0.1% in the general population. It is estimated that 5% of pituitary adenomas occur in a familial setting, either in isolated or syndromic form. Recently, loss-of-function mutations in genes encoding succinate dehydrogenase subunits ( LEARNING POINTS: Pituitary adenomas may be the presenting and/or sole feature of

Identifiers

PMID30087776
PMCPMC6063986
OpenAlexW2883128023

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.